How are Losartan Potassium adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Losartan Potassium, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Losartan Potassium is flagged as the suspect drug causing the adverse event.
What are the most common Losartan Potassium adverse events reported to the FDA?
Renal Failure Acute | 428 (1.63%) |
Dizziness | 397 (1.51%) |
Blood Pressure Increased | 378 (1.44%) |
Hypotension | 318 (1.21%) |
Hyponatraemia | 284 (1.08%) |
Headache | 267 (1.02%) |
Diarrhoea | 257 (.98%) |
Dyspnoea | 256 (.97%) |
Hypertension | 254 (.97%) |
Malaise | 250 (.95%) |
Drug Interaction | 242 (.92%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Losartan Potassium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Losartan Potassium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Losartan Potassium adverse events reported to the FDA?
Neurological | 1490 (5.67%) |
Epidermal And Dermal Conditions | 1029 (3.92%) |
Renal Disorders | 994 (3.78%) |
Electrolyte And Fluid Balance Condi... | 983 (3.74%) |
Respiratory | 944 (3.59%) |
Cardiac And Vascular Investigations | 890 (3.39%) |
Gastrointestinal Signs | 874 (3.33%) |
Cardiac Arrhythmias | 692 (2.63%) |
Therapeutic And Nontherapeutic Effe... | 659 (2.51%) |
Muscle | 599 (2.28%) |
Decreased And Nonspecific Blood Pre... | 576 (2.19%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Losartan Potassium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Losartan Potassium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Losartan Potassium, according to those reporting adverse events to the FDA?
Hypertension | 9677 |
Product Used For Unknown Indication | 1500 |
Drug Use For Unknown Indication | 1334 |
Blood Pressure | 759 |
Essential Hypertension | 250 |
Cardiac Disorder | 182 |
Show More |
Label | Labeler | Effective |
---|---|---|
Losartan Potassium | MedVantx, Inc. | 21-JAN-10 |
Losartan Potassium And Hydrochlorothiazide | Physicians Total Care, Inc. | 26-APR-10 |
Losartan Potassium | Bryant Ranch Prepack | 10-MAY-10 |
Losartan Potassium | Sandoz Inc. | 25-JUN-10 |
Losartan Potassium And Hydrochlorothiazide | Sandoz Inc. | 25-JUN-10 |
Losartan Potassium | Greenstone LLC | 08-NOV-10 |
Losartan Potassium And Hydrochlorothiazide | Greenstone LLC | 19-NOV-10 |
Losartan Potassium And Hydrochlorothiazide | MedVantx, Inc. | 20-DEC-10 |
Losartan Potassium | MedVantx, Inc. | 28-DEC-10 |
Losortan Potassium | Rebel Distributors Corp | 03-JAN-11 |
Hyzaar | Rebel Distributors Corp | 04-JAN-11 |
Losartan Potassium And Hydrochlorothiazide | UDL Laboratories, Inc. | 07-JAN-11 |
Losartan Potassium | NCS HealthCare of KY, Inc dba Vangard Labs | 27-JAN-11 |
Losartan Potassium | Lupin Pharmaceuticals, Inc | 02-FEB-11 |
Losartan Potassium And Hydrochlorothiazide | Watson Laboratories, Inc. | 02-MAR-11 |
Losartan Potassium | UDL Laboratories, Inc. | 11-MAR-11 |
Losortan Potassium | American Health Packaging | 12-APR-11 |
Losartan Potassium And Hydrochlorothiazide | Rebel Distributors Corp | 13-APR-11 |
Losartan Potassium | Endo Pharmaceuticals Inc. DBA Endo Generic Products | 13-APR-11 |
Losartan Potassium | Preferred Pharmaceuticals, Inc | 13-MAY-11 |
Losartan Potassium | PACK Pharmaceuticals, LLC | 01-JUN-11 |
Losartan Potassium And Hydrochlorothiazide | McKesson Packaging Services a business unit of McKesson Corporation | 01-JUN-11 |
Losartan Potassium | McKesson Packaging Services a business unit of McKesson Corporation | 01-JUN-11 |
Losartan Potassium | Golden State Medical Supply, Inc. | 01-JUL-11 |
Losartan Potassium | Unit Dose Services | 13-JUL-11 |
Losartan Potassium | Unit Dose Services | 13-JUL-11 |
Losartan Potassium | Unit Dose Services | 13-JUL-11 |
Losartan Potassium | REMEDYREPACK INC. | 15-JUL-11 |
Losartan Potassium And Hydrochlorothiazide | STAT RX USA LLC | 28-JUL-11 |
Losartan Potassium And Hydrochlorothiazide | Rebel Distributors Corp | 13-SEP-11 |
Losortan Potassium | Rebel Distributors Corp | 21-SEP-11 |
Losartan Potassium | Dispensing Solutions, Inc. | 06-OCT-11 |
Losartan Potassium | STAT Rx USA LLC | 24-OCT-11 |
Hyzaar | PD-Rx Pharmaceuticals, Inc. | 21-NOV-11 |
Cozaar | PD-Rx Pharmaceuticals, Inc. | 21-NOV-11 |
Losartan Potassium | REMEDYREPACK INC. | 07-DEC-11 |
Losartan Potassium | Qualitest Pharmaceuticals | 04-JAN-12 |
Losortan Potassium | PD-Rx Pharmaceuticals, Inc. | 13-JAN-12 |
Losartan Potassium And Hydrochlorothiazide | Dispensing Solutions, Inc. | 17-FEB-12 |
Losartan Potassium | Life Line Home Care Services, Inc. | 17-FEB-12 |
Losartan Potassium And Hydrochlorothiazide | Dispensing Solutions, Inc. | 20-FEB-12 |
Losartan Potassium And Hydrochlorothiazide | Qualitest Pharmaceuticals | 28-FEB-12 |
Losartan Potassium | Cardinal Health | 12-APR-12 |
Cozaar | Cardinal Health | 24-APR-12 |
Losartan Potassium And Hydrochlorothiazide | Apotex Corp. | 21-MAY-12 |
Losartan Potassium | Macleods Pharmaceuticals Limited | 06-JUN-12 |
Losartan Potassium | Apotex Corp | 22-JUN-12 |
Losartan Potassium | Roxane Laboratories, Inc. | 10-AUG-12 |
Losartan Potassium And Hydrochlorothiazide | Mylan Pharmaceuticals Inc. | 27-AUG-12 |
Losartan Potassium | Physicians Total Care, Inc. | 05-SEP-12 |
Cozaar | Physicians Total Care, Inc. | 01-OCT-12 |
Losartan Potassium And Hydrochlorothiazide | Jubilant Cadista Pharmaceuticals Inc. | 01-OCT-12 |
Losartan Potassium | Legacy Pharmaceutical Packaging | 05-OCT-12 |
Losortan Potassium | Bryant Ranch Prepack | 12-OCT-12 |
Losortan Potassium | Bryant Ranch Prepack | 12-OCT-12 |
Losartan Potassium And Hydrochlorothiazide | Legacy Pharmaceutical Packaging | 17-OCT-12 |
Losartan Potassium | Aurobindo Pharma Limited | 22-OCT-12 |
Losartan Potassium And Hydrochlorothiazide | Aurobindo Pharma Limited | 24-OCT-12 |
Losartan Potassium | Mylan Pharmaceuticals Inc. | 31-OCT-12 |
Hyzaar | Physicians Total Care, Inc. | 02-NOV-12 |
Losartan Potassium And Hydrochlorothiazide | Roxane Laboratories, Inc. | 05-NOV-12 |
Losartan Potassium | Sandoz Inc | 13-NOV-12 |
Losortan Potassium | Lake Erie Medical DBA Quality Care Products LLC | 13-NOV-12 |
Cozaar | Merck Sharp & Dohme Corp. | 19-NOV-12 |
Hyzaar | Merck Sharp & Dohme Corp. | 19-NOV-12 |
Losartan Potassium | Micro Labs Limited | 23-NOV-12 |
Losartan Potassium And Hydrochlorothiazide | Teva Pharmaceuticals USA Inc | 27-NOV-12 |
Losartan Potassium | Teva Pharmaceuticals USA Inc | 30-NOV-12 |
Losartan Potassium | NorthStar Rx LLC | 30-NOV-12 |
Losartan Potassium And Hydrochlorothiazide | NorthStar Rx LLC | 20-DEC-12 |
Losartan Potassium | REMEDYREPACK INC. | 27-DEC-12 |
Losartan Potassium And Hydrochlorothiazide | Lupin Pharmaceuticals, Inc. | 07-JAN-13 |
Cozaar | Bryant Ranch Prepack | 18-JAN-13 |
Cozaar | Bryant Ranch Prepack | 18-JAN-13 |
Hyzaar | Bryant Ranch Prepack | 18-JAN-13 |
Losartan Potassium | Torrent Pharmaceuticals Limited | 24-JAN-13 |
Losartan Potassium | Roxane Laboratories, Inc. | 25-JAN-13 |
Losartan Potassium | Preferred Pharmaceuticals, Inc. | 25-JAN-13 |
Losartan Potassium And Hydrochlorothiazide | Torrent Pharmaceuticals Limited | 25-JAN-13 |
Losartan Potassium And Hydrochlorothiazide | Lake Erie Medical DBA Quality Care Products LLC | 05-FEB-13 |
Losartan Potassium And Hydrochlorothiazide | REMEDYREPACK INC. | 09-FEB-13 |
Losartan Potassium And Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 16-FEB-13 |
Losartan Potassium | REMEDYREPACK INC. | 26-FEB-13 |
Losartan Potassium | Watson Laboratories, Inc. | 27-FEB-13 |
Losartan Potassium And Hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | 01-MAR-13 |
Losartan Potassium And Hydrochlorothiazide | Bryant Ranch Prepack | 06-MAR-13 |
Losartan Potassium And Hydrochlorothiazide | Cadila Healthcare Limited | 08-MAR-13 |
Losartan Potassium | REMEDYREPACK INC. | 08-MAR-13 |
Losortan Potassium | Cardinal Health | 13-MAR-13 |
Losortan Potassium | Zydus Pharmaceuticals (USA) Inc. | 06-APR-13 |
Losartan Potassium And Hydrochlorothiazide | Sandoz Inc | 09-APR-13 |
Losartan Potassium | Cadila Healthcare Limited | 09-APR-13 |
Losartan Potassium | McKesson Contract Packaging | 10-APR-13 |
Losartan Potassium | Sandoz Inc | 18-APR-13 |
Losartan Potassium | Qualitest Pharmaceuticals | 24-APR-13 |
Losartan Potassium | Qualitest Pharmaceuticals | 03-MAY-13 |
Losartan Potassium And Hydrochlorothiazide | Qualitest Pharmaceuticals | 03-MAY-13 |
What Losartan Potassium safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Losartan Potassium. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Losartan Potassium.